References
- Turan C, Ozkan U, Ozokutan BH, Ozdemir M, Okur H, Küçükaydin M. Corrosive injuries of the esophagus in newborns. Pediatr Surg Int. 2000;16(7):483–484. doi:10.1007/s003830000420.
- Niedzielski A, Schwartz SG, Partycka-Pietrzyk K, Mielnik-Niedzielska G. Caustic agents ingestion in children: a 51-year retrospective cohort study. Ear Nose Throat J. In press.
- Alser O, Hamouri S, Novotny NM. Esophageal caustic injuries in pediatrics: a sobering global health issue. Asian Cardiovasc Thorac Ann. 2019;27(6):431–435. doi:10.1177/0218492319842441.
- Chirica M, Bonavina L, Kelly MD, Sarfati E, Cattan P. Caustic ingestion. Lancet. 2017;389(10083):2041–2052. doi:10.1016/S0140-6736(16)30313-0.
- Adam JS, Birck HG. Pediatric caustic ingestion. Ann Otol Rhinol Laryngol. 1982;91(6 Part 1):656–658. doi:10.1177/000348948209100629.
- Atabek C, Surer I, Demirbag S, Caliskan B, Ozturk H, Cetinkursun S. Increasing tendency in caustic esophageal burns and long-term polytetrafluorethylene stenting in severe cases: 10 years experience. J Pediatr Surg. 2007;42(4):636–640. doi:10.1016/j.jpedsurg.2006.12.012.
- Contini S, Scarpignato C. Caustic injury of the upper gastrointestinal tract: a comprehensive review. World J Gastroenterol. 2013;19(25):3918–3930. doi:10.3748/wjg.v19.i25.3918.
- Park KS. Evaluation and management of caustic injuries from ingestion of acid or alkaline substances. Clin Endosc. 2014;47(4):301–307. doi:10.5946/ce.2014.47.4.301.
- Türkyilmaz Z, Sönmez K, Karabulut R, et al. Mitomycin C decreases the rate of stricture formation in caustic esophageal burns in rats. Surgery. 2009;145(2):219–225. doi:10.1016/j.surg.2008.10.007.
- De Lusong MAA, Timbol ABG, Tuazon D. Management of esophageal caustic injury. World J Gastrointest Pharmacol Ther. 2017;8(2):90–98. doi:10.4292/wjgpt.v8.i2.90.
- Yagmurlu A, Aksu B, Bingol-Kologlu M, et al. A novel approach for preventing esophageal stricture formation: sphingosylphosphorylcholine-enhanced tissue remodeling. Pediatr Surg Int. 2004;20(10):778–782. doi:10.1007/s00383-004-1145-3.
- Sharifi-Rad M, Varoni EM, Iriti M, Martorell M, Setzer WN, Del Mar Contreras M. Carvacrol and human health: a comprehensive review. Phytother Res. 2018;32(9):1675–1687. doi:10.1002/ptr.6103.
- Aligiannis N, Kalpoutzakis E, Mitaku S, Chinou IB. Composition and antimicrobial activity of the essential oils of two Origanum species. J Agric Food Chem. 2001;49(9):4168–4170.
- Rubio L, Motilva MJ, Romero MP. Recent advances in biologically active compounds in herbs and spices: a review of the most effective antioxidant and anti-inflammatory active principles. Crit Rev Food Sci Nutr.2013;53(9):943–953. doi:10.1080/10408398.2011.574802.
- Aristatile B, Al-Assaf AH, Pugalendi KV. Carvacrol suppresses the expression of inflammatory marker genes in d-galactosamine-hepatotoxic rats. Asian Pac J Trop Med. 2013;6(3):205–211. doi:10.1016/S1995-7645(13)60024-3.
- Arigesavan K, Sudhandiran G. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats. Biochem Biophys Res Commun. 2015;461(2):314–320. doi:10.1016/j.bbrc.2015.04.030.
- Jayakumar S, Madankumar A, Asokkumar S, et al. Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol Cell Biochem. 2012;360(1-2):51–60. doi:10.1007/s11010-011-1043-7.
- Xu J, Zhou F, Ji BP, Pei RS, Xu N. The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Lett Appl Microbiol. 2008;47(3):174–179. doi:10.1111/j.1472-765X.2008.02407.x.
- Vale-Silva L, Silva MJ, Oliveira D, et al. Correlation of the chemical composition of essential oils from Origanum vulgare subsp. virens with their in vitro activity against pathogenic yeasts and filamentous fungi. J Med Microbiol. 2012;61(2):252–260. doi:10.1099/jmm.0.036988-0.
- Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 1995;375(6532):577–581. doi:10.1038/375577a0.
- Thornberry NA, Rano TA, Peterson EP, et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997;272(29):17907–17911. doi:10.1074/jbc.272.29.17907.
- Johnson TS, Griffin M, Thomas GL, et al. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest. 1997;99(12):2950–2960. doi:10.1172/JCI119490.
- Senturk E, Sen S, Pabuccu E, Unsal C, Meteoglu I. New experimental corrosive esophagitis model in rats. Pediatr Surg Int. 2010;26(3):257–261. doi:10.1007/s00383-009-2546-0.
- Uygun I. Caustic oesophagitis in children: prevalence, the corrosive agents involved, and management from primary care through to surgery. Curr Opin Otolaryngol Head Neck Surg. 2015;23(6):423–432. doi:10.1097/MOO.0000000000000198.
- Yukselen V, Karaoglu AO, Ozutemiz O, Yenisey C, Tuncyurek M. Ketotifen ameliorates development of fibrosis in alkali burns of the esophagus. Pediatr Surg Int. 2004;20(6):429–433.
- Bakan V, Ciralik H, Kartal S. A corrosive oesophageal burn model in rats: double-lumen central venous catheter usage. Afr J Paediatr Surg. 2015;12(4):247–250. doi:10.4103/0189-6725.172560.
- Elmas O, Cevik M, Demir T, Ketani MA. Effect of oral tamoxifen on the healing of corrosive oesophageal burns in an experimental rat model. Interact Cardiovasc Thorac Surg. 2014;19(3):351–356. doi:10.1093/icvts/ivu185.
- Akbal E, Koklu S, Karaca G, et al. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model. Dis Esophagus.2012;25(3):188–194. doi:10.1111/j.1442-2050.2011.01231.x.
- Herek O, Karabul M, Yenisey C, Erkus M. Protective effects of ibuprofen against caustic esophageal burn injury in rats. Pediatr Surg Int. 2010;26(7):721–727. doi:10.1007/s00383-010-2618-1.
- Ozbayoglu A, Sonmez K, Karabulut R, et al. Effect of polaprezinc on experimental corrosive esophageal burns in rats. Dis Esophagus. 2017;30(11):1–6. doi:10.1093/dote/dox104.
- Orozco-Perez J, Aguirre-Jauregui O, Salazar-Montes AM, Sobrevilla-Navarro AA, Lucano-Landeros MS, Armendáriz-Borunda J. Pirfenidone prevents rat esophageal stricture formation. J Surg Res. 2015;194(2):558–564. doi:10.1016/j.jss.2014.11.009.
- Prathyusha P, Subramanian MS, Nisha MC, Santhanakrishnan R, Seena MS. Pharmacognostical and phytochemical studies on Origanum vulgare L.(Laminaceae). Anc Sci Life. 2009;29(2):17–23.
- Friedman M. Chemistry and multibeneficial bioactivities of carvacrol (4-isopropyl-2-methylphenol), a component of essential oils produced by aromatic plants and spices. J Agric Food Chem. 2014;62(31):7652–7670. doi:10.1021/jf5023862.
- Memar MY, Raei P, Alizadeh N, Akbari Aghdam M, Kafil HS. Carvacrol and thymol: strong antimicrobial agents against resistant isolates. Rev Med Microbiol. 2017;28(2):63–68. doi:10.1097/MRM.0000000000000100.
- Ozturk H, Cetinkaya A, Duzcu SE, Tekce BK, Ozturk H. Carvacrol attenuates histopathogic and functional impairments induced by bilateral renal ischemia/reperfusion in rats. Biomed Pharmacother. 2018;98:656–661. doi:10.1016/j.biopha.2017.12.060.
- Teodorczyk-Injeyan JA, Cembrzynska-Nowak M, Lalani S, Peters WJ, Mills GB. Immune deficiency following thermal trauma is associated with apoptotic cell death. J Clin Immunol. 1995;15(6):318–328. doi:10.1007/BF01541322.
- Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246(4935):1306–1309. doi:10.1126/science.2479986.